Profil
Jenny Sundqvist currently works at Navinci Diagnostics AB, as Chief Executive Officer.
Ms. Sundqvist also formerly worked at Flerie AB, as Chief Executive Officer, Isofol Medical AB, as Chief Commercial Officer, and AstraZeneca PLC, as Head-Oncology Portfolio from 2017 to 2021.
Ms. Sundqvist received her undergraduate degree from Louisiana State University and Masters Business Admin degree from McCombs School of Business.
Postes actifs de Jenny Sundqvist
| Sociétés | Poste | Début |
|---|---|---|
Navinci Diagnostics AB
Navinci Diagnostics AB BiotechnologyHealth Technology Operates as biotechnology company | Directeur Général | - |
Anciens postes connus de Jenny Sundqvist
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2021 |
| FLERIE INVEST AB | Directeur Général | - |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Formation de Jenny Sundqvist
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Louisiana State University
Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Isofol Medical AB
Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
McCombs School of Business
McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Navinci Diagnostics AB
Navinci Diagnostics AB BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
















